Role of the ETB receptor in retinal ganglion cell death in glaucoma

Raghu Krishnamoorthy, Vidhya R. Rao, Rachel Dauphin, Ganesh Prasanna, Christina Johnson, Thomas Yorio

Research output: Contribution to journalArticleResearchpeer-review

34 Citations (Scopus)

Abstract

Recent observations suggest that the vasoactive peptide endothelin-1 (ET-1) may be an important contributor to the etiology of glaucoma. ET-1 administration has been shown to produce optic nerve axonal loss and apoptosis of retinal ganglion cells. Ocular ET-1 levels are elevated in aqueous humor in response to elevated intraocular pressure both in glaucoma patients and in animal models of glaucoma; however, the precise mechanisms by which ET-1 mediates glaucomatous optic neuropathy are not clear. Presently we report that ET-1-mediated apoptosis was markedly attenuated in ETB receptor-deficient rats, suggesting a key role for ETB receptors in apoptosis of retinal ganglion cells by ET-1 treatment. Using virally transformed rat retinal ganglion cells (RGC-5 cells), we found that ET-1 (100 nmol/L) treatment produced apoptotic changes in these cells that was determined by flow cytometric analyses, release of mitochondrial cytochrome c to the cytosol, and increased phosphorylation of c-Jun N-terminal kinase. Pretreatment with the ETB-receptor antagonist BQ788 (1 μmol/L) was able to significantly attenuate ET-1-mediated apoptosis in RGC-5 cells. ET-1-mediated apoptotic changes in RGC-5 cells were associated with ETB-receptor activation and were accompanied by a significant upregulation of ETB-receptor expression. These studies suggest that ocular ET-1 acts through ETB receptors to mediate apoptosis of retinal ganglion cells, a key event in glaucoma and related optic neuropathies.

Original languageEnglish
Pages (from-to)380-393
Number of pages14
JournalCanadian Journal of Physiology and Pharmacology
Volume86
Issue number6
DOIs
StatePublished - 1 Jun 2008

Fingerprint

Retinal Ganglion Cells
Endothelin-1
Glaucoma
Cell Death
Apoptosis
Optic Nerve Diseases
JNK Mitogen-Activated Protein Kinases
Aqueous Humor
Optic Nerve
Cytochromes c
Intraocular Pressure
Cytosol
Up-Regulation
Animal Models
Phosphorylation
Peptides

Keywords

  • Apoptosis
  • Endothelin receptor B
  • Endothelin-1
  • Neuroprotection
  • Optic neuropathy
  • Retinal ganglion cells (RGCs)

Cite this

Krishnamoorthy, Raghu ; Rao, Vidhya R. ; Dauphin, Rachel ; Prasanna, Ganesh ; Johnson, Christina ; Yorio, Thomas. / Role of the ETB receptor in retinal ganglion cell death in glaucoma. In: Canadian Journal of Physiology and Pharmacology. 2008 ; Vol. 86, No. 6. pp. 380-393.
@article{d38d833a543146d0932cc0cb1e1eb256,
title = "Role of the ETB receptor in retinal ganglion cell death in glaucoma",
abstract = "Recent observations suggest that the vasoactive peptide endothelin-1 (ET-1) may be an important contributor to the etiology of glaucoma. ET-1 administration has been shown to produce optic nerve axonal loss and apoptosis of retinal ganglion cells. Ocular ET-1 levels are elevated in aqueous humor in response to elevated intraocular pressure both in glaucoma patients and in animal models of glaucoma; however, the precise mechanisms by which ET-1 mediates glaucomatous optic neuropathy are not clear. Presently we report that ET-1-mediated apoptosis was markedly attenuated in ETB receptor-deficient rats, suggesting a key role for ETB receptors in apoptosis of retinal ganglion cells by ET-1 treatment. Using virally transformed rat retinal ganglion cells (RGC-5 cells), we found that ET-1 (100 nmol/L) treatment produced apoptotic changes in these cells that was determined by flow cytometric analyses, release of mitochondrial cytochrome c to the cytosol, and increased phosphorylation of c-Jun N-terminal kinase. Pretreatment with the ETB-receptor antagonist BQ788 (1 μmol/L) was able to significantly attenuate ET-1-mediated apoptosis in RGC-5 cells. ET-1-mediated apoptotic changes in RGC-5 cells were associated with ETB-receptor activation and were accompanied by a significant upregulation of ETB-receptor expression. These studies suggest that ocular ET-1 acts through ETB receptors to mediate apoptosis of retinal ganglion cells, a key event in glaucoma and related optic neuropathies.",
keywords = "Apoptosis, Endothelin receptor B, Endothelin-1, Neuroprotection, Optic neuropathy, Retinal ganglion cells (RGCs)",
author = "Raghu Krishnamoorthy and Rao, {Vidhya R.} and Rachel Dauphin and Ganesh Prasanna and Christina Johnson and Thomas Yorio",
year = "2008",
month = "6",
day = "1",
doi = "10.1139/Y08-040",
language = "English",
volume = "86",
pages = "380--393",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "6",

}

Role of the ETB receptor in retinal ganglion cell death in glaucoma. / Krishnamoorthy, Raghu; Rao, Vidhya R.; Dauphin, Rachel; Prasanna, Ganesh; Johnson, Christina; Yorio, Thomas.

In: Canadian Journal of Physiology and Pharmacology, Vol. 86, No. 6, 01.06.2008, p. 380-393.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Role of the ETB receptor in retinal ganglion cell death in glaucoma

AU - Krishnamoorthy, Raghu

AU - Rao, Vidhya R.

AU - Dauphin, Rachel

AU - Prasanna, Ganesh

AU - Johnson, Christina

AU - Yorio, Thomas

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Recent observations suggest that the vasoactive peptide endothelin-1 (ET-1) may be an important contributor to the etiology of glaucoma. ET-1 administration has been shown to produce optic nerve axonal loss and apoptosis of retinal ganglion cells. Ocular ET-1 levels are elevated in aqueous humor in response to elevated intraocular pressure both in glaucoma patients and in animal models of glaucoma; however, the precise mechanisms by which ET-1 mediates glaucomatous optic neuropathy are not clear. Presently we report that ET-1-mediated apoptosis was markedly attenuated in ETB receptor-deficient rats, suggesting a key role for ETB receptors in apoptosis of retinal ganglion cells by ET-1 treatment. Using virally transformed rat retinal ganglion cells (RGC-5 cells), we found that ET-1 (100 nmol/L) treatment produced apoptotic changes in these cells that was determined by flow cytometric analyses, release of mitochondrial cytochrome c to the cytosol, and increased phosphorylation of c-Jun N-terminal kinase. Pretreatment with the ETB-receptor antagonist BQ788 (1 μmol/L) was able to significantly attenuate ET-1-mediated apoptosis in RGC-5 cells. ET-1-mediated apoptotic changes in RGC-5 cells were associated with ETB-receptor activation and were accompanied by a significant upregulation of ETB-receptor expression. These studies suggest that ocular ET-1 acts through ETB receptors to mediate apoptosis of retinal ganglion cells, a key event in glaucoma and related optic neuropathies.

AB - Recent observations suggest that the vasoactive peptide endothelin-1 (ET-1) may be an important contributor to the etiology of glaucoma. ET-1 administration has been shown to produce optic nerve axonal loss and apoptosis of retinal ganglion cells. Ocular ET-1 levels are elevated in aqueous humor in response to elevated intraocular pressure both in glaucoma patients and in animal models of glaucoma; however, the precise mechanisms by which ET-1 mediates glaucomatous optic neuropathy are not clear. Presently we report that ET-1-mediated apoptosis was markedly attenuated in ETB receptor-deficient rats, suggesting a key role for ETB receptors in apoptosis of retinal ganglion cells by ET-1 treatment. Using virally transformed rat retinal ganglion cells (RGC-5 cells), we found that ET-1 (100 nmol/L) treatment produced apoptotic changes in these cells that was determined by flow cytometric analyses, release of mitochondrial cytochrome c to the cytosol, and increased phosphorylation of c-Jun N-terminal kinase. Pretreatment with the ETB-receptor antagonist BQ788 (1 μmol/L) was able to significantly attenuate ET-1-mediated apoptosis in RGC-5 cells. ET-1-mediated apoptotic changes in RGC-5 cells were associated with ETB-receptor activation and were accompanied by a significant upregulation of ETB-receptor expression. These studies suggest that ocular ET-1 acts through ETB receptors to mediate apoptosis of retinal ganglion cells, a key event in glaucoma and related optic neuropathies.

KW - Apoptosis

KW - Endothelin receptor B

KW - Endothelin-1

KW - Neuroprotection

KW - Optic neuropathy

KW - Retinal ganglion cells (RGCs)

UR - http://www.scopus.com/inward/record.url?scp=44949197755&partnerID=8YFLogxK

U2 - 10.1139/Y08-040

DO - 10.1139/Y08-040

M3 - Article

VL - 86

SP - 380

EP - 393

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 6

ER -